Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

FUNCTION OF PATENT ATTORNEY: DEFENSE AGAINST PATENT INVALIDATION OR ROBBERY

Two judges of the Federal Circuit appear to agree with Facebook Inc. that patents on moving a phone to change the part of a map being displayed are invalid as abstract.

https://news.bloomberglaw.com/ip-law/federal-circuit-judges-signal-support-for-facebook-patent-win

The USPTO is the third-busiest forum for determinations of patent validity in the United States. Yet only about 5% of the more than 1,000 AIA petitions to date have involved biotechnology or pharmaceutical patents. Pharmaceutical companies have not generally taken advantage of new litigation strategies available under the AIA. The companies that do so will be better positioned to gain or retain market share.

https://news.bloomberglaw.com/pharma-and-life-sciences/new-ways-to-invalidate-pharmaceutical-patentsbrands-and-generics-need-to-change-their-intellectual-property-business-models

Dr. Patrice P. Jean is the Chair of the Life Sciences Practice at Hughes Hubbard & Reed, an international law firm based in New York City. She has over a decade of experience counselling leading and startup pharmaceutical, chemical and biotechnology companies in all areas of patent law, including asserting and defending patent rights underlying core technologies and innovations. Dr. Jean graduated summa cum laude from Xavier University of Louisiana in 1993 with a degree in biochemistry, and she holds a Ph.D. in molecular biology from Princeton University. She graduated from Columbia University School of Law in 2002, where she was Editor-in-Chief of the Columbia Science & Technology Law Review. Dr. Jean currently serves as Vice-President of the New York Intellectual Property Law Education Foundation and is a Board member of the New York Intellectual Property Law Association.

We will be just fine....

~ J-Belfort, iHub RLFTF board